Whom to Evaluate for Cardiac Amyloidosis: ASNC/Multisocietal Expert Consensus Recommendations

Date: December 11, 2019

Time: 12:00PM - 01:00PM

You must be registered to participate!

Learning Objectives:

• Review the Expert Consensus Recommendations (ECR) for cardiac amyloidosis imaging in clinical practice
• Demonstrate appropriate use of the ECR in clinical practice using multiple case studies
• Provide clinical insights to diagnosis and management of cardiac amyloidosis

Agenda

• Overview of Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis
• Case Studies
  • Identifying cardiac involvement: No cardiac symptoms
  • Screening for cardiac amyloidosis: New symptomatic heart failure
  • Evaluation of biopsy proven AL amyloidosis
  • Evaluation of biopsy proven ATTR amyloidosis
  • Follow-up testing: New or worsening cardiac symptoms
  • Other clinical conditions associated with amyloidosis
• Summary and recommendations

This activity is sponsored by Pfizer. No CME/CE credit is available for this webinar.

Moderator(s):

• Sharmila Dorbala, MD, MPH, FASNC, Brigham and Women’s Hospital, Boston, MA

Speaker(s):

• Jamieson M. Bourque, MD, MHS, FASNC, Associate Professor of Medicine and Radiology, University of Virginia Health Systems
• Brett W. Sperry, MD, Saint Luke’s Mid America Heart Institute, Kansas City, MO
• Mathew S. Maurer, MD, Columbia University Medical Center, New York, NY
• Rodney H. Falk, MD, Associate Professor, Harvard Medical School, Cardiovascular Medicine, Director, Cardiac Amyloidosis Program Brigham and Women’s Hospital Boston, MA